Inventor
BERESIS RICHARD THOMAS
US21 patents
⚠️ This page may combine multiple inventors who share the name “BERESIS RICHARD THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SAGE THERAPEUTICS INC
15 patentsUS9725481B2Aug 8, 2017
19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
SAGE THERAPEUTICS INC46 citations98
US9512165B2Dec 6, 2016
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC71 citations98
US9365611B2Jun 14, 2016
19-NOR neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC49 citations98
US11241446B2Feb 8, 2022
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC12 citations94
US10342810B2Jul 9, 2019
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC17 citations94
US10172871B2Jan 8, 2019
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC20 citations94
US11344563B2May 31, 2022
19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
SAGE THERAPEUTICS INC8 citations86
US11261211B2Mar 1, 2022
19-NOR neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC8 citations86
US10774108B2Sep 15, 2020
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC12 citations86
US10822370B2Nov 3, 2020
19-nor neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC13 citations85
US10377790B2Aug 13, 2019
19-nor neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC8 citations84
US10023606B2Jul 17, 2018
19-nor neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC11 citations84
US11945836B2Apr 2, 2024
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC3 citations75
US12201640B2Jan 21, 2025
19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC0 citations63
US11912737B2Feb 27, 2024
19-nor neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC0 citations62
DYNAVAX TECH CORP
3 patentsUS11370794B2Jun 28, 2022
Toll-like receptor antagonist compounds and methods of use
DYNAVAX TECH CORP3 citations70
US12378255B2Aug 5, 2025
Toll-like receptor antagonist compounds and methods of use
DYNAVAX TECH CORP0 citations60
US11827641B2Nov 28, 2023
Toll-like receptor antagonist compounds and methods of use
DYNAVAX TECH CORP1 citations60